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Abstract
Unilateral injection of 50 nmol of N-methyl-D-aspartate (NMDA) into the left posterior striatum of 7 day-old rat pups
induces massive neuronal loss in the ipsilateral hemisphere in 5 days. In this model of excitotoxicity, the form of neuronal death
(necrosis vs apoptosis) has not been clearly addressed. Here we report evidence of DNA laddering in the ipsilateral hemisphere
24 h after the NMDA injection. Activation of apoptosis-linked caspase(s) was also identi®ed, as evidenced by (i) the formation
of caspase-produced 120 kDa alpha-spectrin breakdown product (SBDP120) and (ii) increase in hydrolysis of caspase-3 substrate
acetyl-DEVD-7-amido-4-methylcoumarin in the homogenate from the ipsilateral hemisphere. Lastly, we note that i.p. injection
(100 mg/kg) of a pan caspase inhibitor Z-D-DCB attenuates the levels of SBDP120. Our results suggest the presence of caspase-
activation in this rat pup model of NMDA toxicity. # 2000 Published by Elsevier Science Ltd. All rights reserved.
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1. Introduction
Programmed cell death (or apoptosis) is character-
ized by a number of features, including cytoplasmic
shrinkage, DNA cleavages in the nucleosome linker
regions and chromatin condensation along the inside
surface of the nuclear envelope as a result of DNA
fragmentation (Cohen, 1993). Terminal deoxyribonu-
cleotidyl transferase (TdT)-mediated biotin-16-dUTP
nick-end labeling (TUNEL) has been a popular
method to identify apoptotic cells as it detects
increases of fragmented DNA (Charriaut-Marlangue et
al., 1995). The mode of cell death during in vivo
model of cerebral ischemia or excitotoxicity has been
generally believed to be necrotic. Linnik et al. (1993)
was the ®rst group to challenge this notion by report-
ing evidence of DNA laddering and TUNEL labeling
in a rat model of focal ischemia. Shortly after,
MacManus et al. (1993) reported similar ®ndings in a
4-vessel-occlusion global ischemia model. Since then
numerous reports appeared documenting the presence
of apoptosis in other focal or global ischemia or kai-
nate toxicity models (Chen et al., 1997; Filipkowski et
al., 1994; Heron et al., 1993; Li et al., 1995a; Petito et
al., 1997). Besides DNA laddering and TUNEL, elec-
tron micrographic analysis has been employed in iden-
tifying apoptotic neurons. Yet using similar
techniques, several research groups found little or no
evidence of classic apoptosis (Dessi et al., 1993; Scott
and Hegyi, 1997; van Lookeren Campagne and Gill,
1996). Using TUNEL method solely to identify apop-
totic cells has now been criticized based on the fact
that it only detects the increase of fragmented DNA,
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(Charriaut-Marlangue and Ben-Ari, 1995). Recently,
neuronal apoptosis has also been identi®ed in spinal
injury and traumatic models (based on evidence of
DNA laddering and apoptotic nuclei morphology).
Ideally, a more de®nitive biochemical marker for
apoptosis would be much preferred to de®ne the pre-
sence of apoptosis.
In recent years, caspase activation has been strongly
linked to apoptosis (Nicholson and Thornberry, 1997).
Caspase-3 and 7 are two highly related mammalian
members that mediate apoptosis. Caspase-3 (previously
called CPP32, Yama, apopain) is found in all cell
types, including central neurons (Ni et al., 1997).
Interestingly, caspase-7 m-RNA is expressed in all tis-
sues but absent in the brain (Juan et al., 1997).
Consistent with that, caspase-3 knockout mice have a
major defect in the machinery of neuronal apoptosis
during development, while peripheral tissues are spared
(Kuida et al., 1996). Neuronal or neural cells in cul-
ture, when subjected to pro-apoptotic challenges
(staurosporine, potassium or growth factor depri-
vation), always result in caspase-3 activation
(Armstrong et al., 1997; Koh et al., 1995; Nath et al.,
1996a; Ni et al., 1997; Wiesner and Dawson, 1996).
During apoptosis, caspase-3 apparently cleaves various
cellular proteins such as poly(ADP-ribose) polymerase
(PARP) (Lazebnik et al., 1994) and nonerythroid a-
spectrin (Martin et al., 1995; Nath et al., 1996a). In
our previous study, we found that although both cal-
pain and caspase-3 are capable of fragmenting a-spec-
trin, only caspase produces the distinct 120 kDa
breakdown product (SBDP120) (Nath et al., 1996a).
We also proposed using the SBDP120 as a potential
marker for apoptosis since several commercial anti-a-
spectrin antibodies crossreact with rat and human
alpha-spectrin (Nath et al., 1996a). In our recent study
(Nath et al., 1998), we used caspase activation (against
a peptidic substrate acetyl-DEVD-AMC) and the pre-
sence of SBDP120 to argue for the presence of an
apoptotic component in both excitotoxin- (NMDA,
kainate) and hypoxia/hypoglycemia-mediated neuronal
death in cerebrocortical cultures. Independently, Du et
al. (1997) also demonstrated that a caspase-3 like pro-
tease is activated in glutamate-challenged cerebellar
granule neurons in culture.
In this study, we used a rat pup model of direct
NMDA toxicity (McDonald et al., 1989). In parallel
with traditional apoptosis markers (DNA laddering,
TUNEL staining), we again sought evidence for cas-
pase-3 activation by the two above-mentioned detec-
tion methods (caspase activity assay with peptidic
substrate acetyl-DEVD-AMC and formation of
SBDP120 on Western blot). We argue that using these
biochemical approaches to earmark apoptosis greatly
complements the more traditional techniques.
2. Materials and methods
2.1. NMDA-induced injury in rat pups
All animal experiments conform to the guidelines set
by Parke-Davis and the Society for Neuroscience.
Sprague-Dawley rat pups (Charles River Laboratories,
Portage, MI) were used on postnatal day 6±7 (average
14 g). Animals were anesthetized by ethyl ether before
50 nmol of NMDA in the form of a saline solution
(0.5 mL of 7.35 mg/mL) or vehicle only was stereotaxi-
cally injected into the right posterior striatum with the
aid of a stereotaxic platform. Caspase inhibitor is
given i.p. (100 mg/kg) in a 5.5% DMF and methocel
vehicle (50 mL). Rat pups were allowed to recover for
2 h in an incubator kept at 368C with a thermostat-
controlled heating coil and then returned to their
cages. After 24 h (unless otherwise stated), the pups
were sacri®ced and their cortical hemispheres were
removed. The hemispheres were individually sub-
merged in ÿ708C cooled isopentane. Frozen brains
were powdered with pre-cooled mortar-pestle over dry
ice. About 50 mg of the samples were added to 0.5 mL
of homogenization buer containing 2% (w/v) SDS,
20 mM Tris-HCl (pH 7.4), 5 mM EDTA, 5 mM
EGTA, 1 mM DTT, 0.5 mM phenylmethylsulfonyl ¯u-
oride, 10 mg/mL 4-(2-aminoethyl)-benzenesulfonyl-
¯uoride, 5 mg/mL leupeptin, 10 mg/mL pepstatin, 10 mg/
mL N-alpha-p-tosyl-L-lysine chloromethyl ketone and
10 mg/mL N-alpha-p-tosyl-L phenylalanine chloro-
methyl ketone for 15±20 min to produce a clear lysate.
One hundred mL of trichloroacetic acid (100% (w/v))
was then added. The precipitated proteins were col-
lected by centrifugation and washed with 1 mL of
2.5% trichloroacetic acid. The protein pellets were
resolubilized with 50 mL of 3 M Tris base and stored
at ÿ208C until use (Wang et al., 1996).
2.2. Protein analysis
Protein concentration in tissue extracts was esti-
mated with a modi®ed Lowry assay (BioRad). Samples
(15 mg of protein) were run on SDS-PAGE (4±20%
acrylamide) with a Tris-glycine running buer system
and then transferred onto a PVDF membrane (0.2 mm)
with Tris-glycine buer system using a semi-dry elec-
trotransfering unit (BioRad) at 20 mA for 1.5±2 h.
The blots were probed with an anti-a-spectrin (mono-
clonal, Chemicon) antibody. The blots were developed
with nitro blue tetrazolium and 5-bromo-4-chloro-3-
indolyl-phosphate. Densitometric analysis of Western
blots was performed using a color scanner (Umax
UC630) and the NIH program Image 1.5.
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The DNA was extracted from rat pup brain
hemispheres using the Easy-DNA kit (Invitrogen).
Brie¯y, the tissue was quick frozen in ice-cold iso-
pentane and pulverized with mortar and pestle. The
DNA was extracted using manufacturer's protocol
and analyzed on a 1.5% agarose gel with 5 mg/mL
ethidium bromide and electrophoresed at 2 V/cm
overnight. The overall levels of DNA fragmentation
on agarose gels was quanti®ed by densitometry
using a computer-driven image scanner (Umax
UC630) and an image analysis software Image 1.5
(From NIH).
Fig. 1. DNA laddering on the ipsilateral hemisphere in rat pups 24 h after NMDA injection. In (A), agarose gel electrophoresis of genomic
DNA from sham-operated or NMDA-injured ipsilateral (I) or contralateral (C) hemispheres at 16 h after injection. The lanes to the far left are
loaded with DNA standards. In (B), DNA fragmentation was quanti®ed as a time course after NMDA injection. Shown are the levels of DNA
fragmentation from the ipsilateral (closed bars) or contralateral (open bars) hemispheres. Data are means2SEM (n = 3). Data signi®cantly
dierent from contralateral are indicated by
 (P < 0.05, ANOVA).
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To assay for caspase-3-like protease, the ipsilateral
and contralateral hemispheres of NMDA-injected rat
pups were separately pulverized over dry ice and por-
tions of the samples were lysed in a buer containing
20 mM Tris-HCl (pH 7.4 at 48C), 150 mM NaCl,
1 mM DTT, 5 mM EDTA, 5 mM EGTA and 1% (w/
v) Triton X-100 for 90 min at 48C. The centrifugation-
cleared lysates were mixed with 50% (v/v) glycerol.
Cell lysates (30 mg protein) were assayed with 100 mM
acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin
(ac-DEVD-MCA; Bachem Bioscience), 100 mM
Hepes, 10% glycerol, 1 mM EDTA, 10 mM DTT and
10 mM Z-D-DCB (optional). Fluorescence (excitation
380 nm215 nm and emission 460 nm215 nm) was
measured at 60 min with Cyto¯or 2300 (Nath et al.,
1996a).
3. Results
3.1. Early evidence of DNA fragmentation and
condensation in NMDA-injured hemispheres
DNA laddering is among one of the more reliable
techniques presently employed to study apoptosis both
in vitro and in vivo. Thus, in the ®rst set of exper-
iments, we examined evidence of DNA fragmentation
by electrophoresing genomic DNA samples from the
NMDA-injected and contralateral hemispheres (24 h
after injection) on agarose gel. As expected, very little
DNA breakdown was detected in either hemispheres
of sham-operated (vehicle-injected) animals (Fig. 1A).
In contrast, ipsilateral hemispheres showed the pre-
sence of distinct DNA ladder in NMDA-injected rat
pups (Fig. 1A). We also quanti®ed the levels of DNA
fragmentation in these samples and found that DNA
fragmentation signi®cantly increased in the NMDA-
injected hemisphere (Fig. 1B). We have also examined
brain samples taken at other time points (8, 16, 24,
48 h) after NMDA injection. We found that small
levels of DNA laddering began to appear on the ipsi-
lateral side after 8 h (results not shown). By 16±24 h,
the DNA fragmentation level in the ipsilateral side
became the most intense. Signi®cant increase of DNA
laddering was also detected in the ipsilateral brain
samples from the 48 h time point (results not shown).
To address whether the DNA laddering signal came
from neuronal or glial population, we next proceeded
with TUNEL staining and counterstained with astro-
cyte marker GFAP of brain sections from NMDA-
injected and sham-operated neonatal rat brains (1 day
post injury). Ipsilateral neocortex in NMDA-injured
rat pups showed widespread TUNEL-positive cells
which are indeed neurons mostly. At higher concen-
trations, we noted that about 30% TUNEL-positive
neurons showed highly condensed chromatin frag-
ments within the nuclei, consistent with apoptotic phe-
notype (data not shown).
3.2. Evidence of caspase activation
To approach the apoptosis issue biochemically, we
took advantage of the following two observations: (i)
caspase-3 activation is linked to processing of caspase-
3; and (ii) only processed form of caspase-3 can cleave
peptidic substrates, such as ac-DEVD-AMC
(Posmantur et al., 1997). We prepared Triton-X100
extracts from pulverized frozen hemispheres. We then
subjected the extracts (equalized by protein amount) to
a caspase activity assay. It utilized two synthetic sub-
strates: ac-YVAD-AMC which is rapidly hydrolysed
by caspase-1 but not caspase-3; ac-DEVD-AMC, on
the other hand, which is rapidly hydrolyzed by cas-
pase-3 but is also a substrate for caspase-1. In this ex-
periment, we examined the possible elevation of
caspase-1 or -3 activity during a time-course post-
NMDA injection. At 1 and 3 h, the levels of ac-
YVAD-AMC and ac-DEVD-AMC hydrolytic activi-
ties are present in both ipsilateral and contralateral
hemispheres (Fig. 2A and 2B). But no signi®cant
dierence between the two hemispheres was detected.
By 18 and 24 h, there is actually a slight decrease in
ac-YVAD-AMC hydrolysis in the NMDA-injected
hemisphere (Fig. 2A). On the other hand, ac-DEVD-
hydrolysis in the NMDA-injured cortex was increased
as early as 6 h and also at 18 and 24 h (Fig. 2B). Since
no caspase-1 activation was observed (based on the
lack of increase of ac-YVAD-AMC hydrolysis) (Fig.
2A), we attributed the increase in ac-DEVD-AMC ac-
tivity to activated caspase-3 in the NMDA-injured
Fig. 2. Time course of caspase-1- and caspase-3-like activities
towards peptide substrates after NMDA injection. Triton X-100
extracts (25 mg protein) from (A) NMDA-injured (closed circles) or
contralateral (open circles) hemispheres at 1, 3, 6, 18 and 24 h after
injection were incubated in a reaction mixture with the caspase-1-
preferred ac-YVAD-AMC peptide substrate (A), or the caspase-3-
preferred ac-DEVD-AMC peptide substrate (B) (see Section 2). Data
are means2SEM (n = 3). Data signi®cantly dierent from contral-
ateral are indicated by
 (P < 0.05, ANOVA) or
 (P < 0.02).
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increase in either ac-DEVD-AMC or ac-YVAD-AMC
hydrolytic activity. Taken together, data in Fig. 2
showed that increase of caspase-3 or a caspase-3 like
activity is observed 6±24 h in the ipsilateral hemisphere
following NMDA injection.
3.3. Formation of a a-spectrin breakdown product
SBDP120 in the NMDA-injured hemisphere
To further monitor caspase-3 activation, we exam-
ined the integrity of one of its best established sub-
strates, a-spectrin. In the sham-operated animals,
protein extracts from both hemispheres showed only
intact a-spectrin (280 kDa), demonstrating that our
extraction method did not introduce arti®cial post-
mortem spectrin degradation, as we have previously
established (Wang et al., 1996) (Fig. 3A). In the
NMDA-injured group, we noted that spectrin break-
down products (SBDPs) began to emerge as early as
6 h and became prominent by 24 h (Fig. 3A). Three
dierent fragments (bearing molecular weights of 150,
Fig. 3. Appearance of apoptosis-speci®c 120 kDa a-spectrin breakdown product in the NMDA injected hemisphere. Immunoblot analysis of a-
spectrin breakdown of rat pup samples from (A) sham-operated (S), or NMDA-injured ipsilateral (ipsil) or contralateral (contra) hemispheres at
1, 3, 6, 18 and 24 h after injection. The intact a-spectrin is indicated by an arrow (280 kDa), the SBDP120 was indicated with open triangle,
while SBDP150 and SBDP145 were indicated by double open triangles. Three individual samples from each time points are shown. (B)
Quanti®cation of the level of apoptosis-speci®c SBDP120 in samples from the ipsilateral (closed circles) or contralateral (open circles) hemi-
spheres. Data are means2SEM (n = 3). Data signi®cantly dierent from contralateral are indicated by
 (P < 0.05, ANOVA).
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spheres from the NMDA treatment group. We have
previously shown that in cultured neurons, necrosis
leads to calpain-mediated SBDP150 and SBDP145
whereas apoptosis produces the calpain-mediated frag-
ments as well as the caspase-3-mediated SBDP150 and
SBDP120 (Nath et al., 1996a,b). Therefore, based on
molecular weight separation, the SBDP120 is an un-
ambiguous marker for caspase-3 activation. We also
quanti®ed the level of SBDP120 against a time course
after NMDA injury. In fact, mirroring the increase of
caspase-3 activity (Fig. 3B), we noted that the level of
caspase-3 speci®c SBDP120 began to rise at a low level
by 6 h, reaching maximal level at 18 and 24 h in the
ipsilateral hemispheres (Fig. 3A and 3B). Again the
contralateral hemispheres showed little SBDP120 over
the same time course (Fig. 3A and 3B) (n = 3).
To further ascertain that the SBDP120 in NMDA-
injured brains is caspase-mediated, we examined the
eects of caspase inhibitor Z-D-DCB on the levels of
NMDA-induced SBDP120. We administered a group
of NMDA-treated rat pups a bolus dose (100 mg/kg in
saline, i.p.) of the low molecular weight (M.W. 454.3),
Z-D-DCB or vehicle alone 30 min after NMDA injec-
tion. The i.p. route was used since the small size of the
rat pups excluded the possibility of i.v. administration.
We have previously shown that Z-D-DCB is very eec-
tive in blocking the caspase-3-mediated SBDP120 in
apoptotic neurons in culture (Nath et al., 1996a). In
this experiment, the protein samples were taken from
the 24 h time point. Again, we noted signi®cant levels
of SBDP120 in the NMDA-injured hemispheres in the
vehicle treatment group (Fig. 4A and 4B). On the
other hand, in the Z-D-DCB treatment group, the ipsi-
lateral hemispheres showed a partial but signi®cant at-
tenuation of the SBDP120 levels (Fig. 4A and 4B).
This suggests that SBDP120 formed in this in vivo
model of excitotoxicity is derived from a caspase or
caspase-like activity.
4. Discussion
In the rat pup model of excitotoxicity, we report evi-
dence of DNA laddering in the ipsilateral hemispheres,
16±24 h after the NMDA injection (Fig. 1). This
echoes several recent reports showing similar evidence
of apoptosis in a kainate toxicity model (Filipkowski
et al., 1994) as well as in focal ischemia models in
which excitotoxicity was implicated (Chen et al., 1997;
Heron et al., 1993; Li et al., 1995a). But we extended
these ®ndings by showing that the apoptosis-linked
caspase-3/7 like protease was activated, as evidenced
by (i) increase in hydrolytic activity of caspase-3 sub-
strate acetyl-DEVD-AMC in the ipsilateral hemisphere
(Fig. 2) and (ii) the formation of caspase inhibitor-sen-
sitive SBDP120 (Figs. 3 and 4). Based on a previous
report that caspase-7 m-RNA is absent in neurons, it
is most likely that caspase-3 is mediating the spectrin
breakdown observed in NMDA-injured neurons. It is
Fig. 4. Caspase inhibitor Z-D-DCB attenuated SBDP120 in NMDA-
injured brains. (A) a-Spectrin breakdown in the ipsilateral (ipsil) and
contralateral (contra) brain hemispheres in rat pups 24 h after
NMDA treatment (NMDA) or NMDA treatment with 100 mg/kg of
Z-D-DCB i.p. injection 30 min after NMDA injection was monitored
(N+Z-D-DCB) as described in Section 2 (six pups for each group).
Each lane represents protein sample (15 mg) from an individual rat
pup. The solid arrows indicate the apoptosis-speci®c SBDP120. (B)
Densitometric quanti®cation of SBDP120 in the ipsilateral hemi-
sphere from either NMDA (open bar) or NMDA+Z-D-DCB trea-
ted (solid bar) rat pups was shown. Data are means2SEM (n = 6).
Data signi®cantly dierent from NMDA alone are indicated by
(P < 0.05, Student's t-test).
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loss of brain mass, which usually takes 1±5 days. In
the current study, we employed an anti-a-spectrin that
detects both the intact protein as well as various frag-
ments including SBDP120. It was an adequate tool
since we performed Western blots analysis, which pro-
vided resolution of the various fragments. We also
established that the majority of TUNEL-positive cells
are neurons rather than astrocytes (results not shown),
thus giving us the con®dence with the notion that the
SBDP120 observed mainly derived from the neuronal
population. We have recently identi®ed the N-terminal
sequence of the SBDP120 (Wang et al., 1998). We
reason that it would be ideal to generate a neo-N-
terminal-speci®c antibody which can be employed in
immunohistochemical staining and other qualitative
and quantitative analysis of caspase activity in vivo
(Wang et al., unpublished work). As caspase-3 is only
activated in apoptosis but not necrosis (Armstrong et
al., 1997), we propose that it will be a powerful yet
simple technique to positively identify individual cells
that are dying from apoptosis, as opposed to the more
elaborated morphological identi®cation by electron mi-
crography. Work is now in progress in our laboratory
to produce SBDP120-speci®c antibodies.
Lastly, several recently available caspase-speci®c in-
hibitors (such as Z-D-DCB, Z-VAD-cmk, ac-YVAD-
cmk, Z-VAD-fmk) are found to be powerful neuronal
apoptosis inhibitors (Hara et al., 1997; Loddick et al.,
1996; Nath et al., 1996a, 1996b; Schulz et al., 1996).
Also they are ineective against necrosis (Armstrong et
al., 1997). Recently caspase inhibitors (Z-VAD-fmk, Z-
DEVD-fmk) have been shown to produce neuroprotec-
tive eects in both a focal ischemia model as well as a
traumatic brain injury model (Endres et al., 1998;
Yakolev et al., 1997). A note of caution is that these
inhibitors are also capable of inhibiting caspase-1.
Beside its potential role in certain forms of apoptosis
(Kuida et al., 1995; Li et al., 1995b), caspase-1 is also
the established pro-interleukin 1beta-converting
enzyme (Thornberry et al., 1992). Thus, pharmacologi-
cal studies using general caspases inhibitors could also
oer neuroprotection by suppressing IL-1beta-
mediated neuro-in¯ammation component after ische-
mia (Schielke et al., 1998). On the other hand,
Namura and et al. (1998) recently showed evidence of
caspase activation in a focal ischemia model in mouse
by using TUNEL, DEVD-based peptide substrate hy-
drolysis and positive staining with an antibody speci®c
to the activated form of caspase-3. Their data and
techniques are in agreement and complement the data
presented here. In conclusion, these recent studies
including the present study show evidence for an
``apoptotic'' component in a given form of neuronal
injury involving excitotoxicity. It also raises the intri-
guing possibility that more powerful and selective cas-
pase inhibitors may have a therapeutic value in the
treatment of various excitotoxin-mediated neurodegen-
erative disorders.
Acknowledgements
We appreciate the assistance and advice of Dr. Lary
Walker in brain slice preparation and TUNEL labeling
and Dr. G. Schielke for critical comments.
References
Armstrong, R.C., Aja, T.J., Hoang, K.D., Gaur, S., Bai, X.,
Alnemri, E.S., Litwack, G., Karanewsky, D.S., Fritz, L.C.,
Tomaselli, K.J., 1997. Activation of the CED3/ICE-related pro-
tease CPP32 in cerebellar granule neurons undergoing apoptosis
but not necrosis. J. Neurosci. 17, 553±562.
Charriaut-Marlangue, C., Margaill, I., Plotkine, M., Ben-Ari, Y.,
1995. Early endonuclease activation following reversible focal
ischemia. J. Cereb. Blood Flow Metab. 15, 385±388.
Charriaut-Marlangue, C., Ben-Ari, Y., 1995. A cautionary note on
the use of TUNEL stain to determine apoptosis. NeuroReport 7,
61±64.
Chen, J., Jin, K., Chen, M., Pei, W., Kawaguchi, K., Greenberg,
D.A., Simon, R.P., 1997. Early detection of DNA strand breaks
in the brain after transient focal ischemia: implications for the
role of DNA damage in apoptosis and neuronal cell death. J.
Neurochem. 69, 232±245.
Cohen, J.J., 1993. Apoptosis. Immunol. Today 14, 126±130.
Dessi, F., Charriaut-Marlangue, C., Khrestchatisky, M., Ben-Ari,
Y., 1993. Glutamate-induced neuronal death is not a pro-
grammed cell death in cerebellar culture. J. Neurochem. 60,
1953±1955.
Du, Y., Bales, K.R., Dodel, R.C., Hamilton-Byrd, E., Horn, J.W.,
Czilli, D.L., Simmons, L.K., Ni, B., Paul, S.M., 1997. Activation
of a caspase-3-related cysteine protease is required for glutamate-
mediated apoptosis if cultured cerebellar granule neruons. In:
Proc. Natl. Acad. Sci. USA 94, pp. 11,657±11,662.
Endres, M., Namura, S., Shimizu-Sasamata, M., Waeber, C., Zhang,
L., Gomez-Isla, T., Hyman, B.T., Moskowitz, M.A., 1998.
Attenuation of delayed neuronal death after mild focal ischemia
in mice by inhibition of the caspase family. J. Cereb. Blood Flow
Metab. 18, 238±247.
Filipkowski, R.K., Hetman, M., Kaminska, B., Kaczmarek, L.,
1994. DNA fragmentation in rat brain after intraperitoneal ad-
ministration of kainate. NeuroReport 5, 1538±1540.
Hara, H., Friedlander, R.M., Gagliardini, V., Ayata, C., Fink, K.,
Huang, Z., Shimizu-Sasamata, M., Yuan, J., Moskowitz, M.A.,
1997. Inhibition of interleukin 1beta converting enzyme family
proteases reduce ischemic and excitotoxic neuronal damage. In:
Proc. Natl. Acad. Sci. USA 94, pp. 2007±2012.
Heron, A., Pollard, H., Dessi, F., Moreau, J., Lasbennes, F., Ben-
Ari, Y., Charriaut-Marlangue, C., 1993. Regional variability in
DNA fragmentation after global ischemia evidenced by combined
histological and gel electrophoresis observations in the rat brain.
J. Neurochem. 61, 1973±1976.
Juan, T.S., McNiece, I.K., Argento, J.M., Jenkins, N.A., Gilbert,
D.J., Copeland, N.G., Fletcher, F.A., 1997. Identi®cation and
mapping of Casp7, a cysteine protease resembling CPP32 beta,
interleukin-1 beta converting enzyme, and CED-3. Genomics 40,
86±93.
Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J.,
R. Nath et al./ Neurochemistry International 36 (2000) 119±126 125Su, M.S., Flavell, R.A., 1995. Altered cytokine export and apop-
tosis in mice de®cient in interleukin-1 beta converting enzyme.
Science 267, 2000±2003.
Kuida, K., Zheng, T., Na, S., Kuan, C., Yang, D., Karasuyama, H.,
Rakic, P., Flavell, R.A., 1996. Decreased apoptosis in the brain
and premature lethality in CPP32-de®cient mice. Nature 384,
368±370.
Lazebnik, Y.A., Kaufman, S.H., Desnoyers, S., Poirier, G.G.,
Earnshaw, W.C., 1994. Cleavage of poly (ADP-ribose) polymer-
ase by a proteinase with properties like ICE. Nature 371, 346±
347.
Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston,
C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne,
E., Tracey, D., Wardwell, S., Wei, F.-Y., Wong, W., Kamen, R.,
Seshadri, T., 1995a. Mice de®cient in IL-1 beta-converting
enzyme are defective in production of mature IL-1 beta and re-
sistant to endotoxic shock. Cell 80, 401±411.
Li, Y., Chopp, M., Jiang, N., Zaloga, C., 1995b. In situ detection of
DNA fragmentation after focal cerebral ischemia in mice. Brain
Res. Mol. Brain Res. 28, 164±168.
Linnik, M.D., Zobrist, R.H., Hat®eld, M.D., 1993. Evidence sup-
porting a role for programmed cell death in focal cerebral ische-
mia in rats. Stroke 24, 2002±2008.
Loddick, S.A., MacKenzie, A., Rothwell, N.J., 1996. An ICE inhibi-
tor, z-VAD-DCB attenuates ischaemic brain damage in the rat.
Neuroreport 7, 1465±1468.
MacManus, J.P., Buchan, A.M., Hill, I.E., Rasquinha, I., Preston,
E., 1993. Global ischemia can cause DNA fragmentation indica-
tive of apoptosis in rat brain. Neurosci. Lett. 164, 89±92.
Martin, S.J., O'Brien, G.A., Nishioka, W.K., McGahon, A.J.,
Mahboubia, T., Saido, T.C., Green, D., 1995. Proteolysis of
fodrin during apoptosis. J. Biol. Chem. 270, 6425±6428.
McDonald, J.W., Silverstein, F.S., Johnston, M.V., 1989.
Neuroprotective eects of MK-801, TCP, PCP and CPP against
N-methyl-D-aspartate induced neurotoxicity in an in vivo perina-
tal rat model. Brain Res. 490, 33±40.
Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A.,
Tomaselli, K.J., Yuan, J., Moskowitz, M.A., 1998. Activation
and cleavage of caspase-3 in apoptosis induced by experimental
cerebral ischemia. J. Neurosci. 18, 3659±3668.
Nath, R., Probert Jr, A., McGinnis, K.M., Wang, K.K.W., 1998.
Evidence for activation of caspase-3-like protease in excitotoxins-
and hypoxia/hypoglycemia-injured neurons. J. Neurochem. 71,
186±195.
Nath, R., Raser, K.J., Staord, D., Hajimohammadreza, I., Posner,
A., Allen, H., Talanian, R.V., Yuen, P.-W., Gilbertsen, R.B.,
Wang, K.K.W., 1996a. Nonerythroid alpha-spectrin breakdown
by calpain and ICE-like protease(s) in apoptotic cells: contribu-
tory roles of both protease families in neuronal apoptosis.
Biochem. J. 319, 683±690.
Nath, R., Raser, K.J., McGinnis, K., Staford, D., Wang, K.K.W.,
1996b. Eects of calpain and ICE-like protease inhibitors on
neuronal apoptosis. NeuroReport 8, 249±256.
Ni, B., Wu, X., Du, Y., Su, Y., Hamilton-Byrd, E., Rockey, P.K.,
Rosteck Jr, P., Poirier, G.G., Paul, S.M., 1997. Cloning and ex-
pression of a rat brain interleukin-1beta-converting enzyme
(ICE)-related protease (IRP) and its possible role in apoptosis of
cultured cerebellar granule neurons. J. Neurosci. 17, 1561±1569.
Nicholson, D.W., Thornberry, N.A., 1997. Caspases: killer proteases.
Trends Biochem. Sci. 22, 299±306.
Petito, C.K., Torres-Munoz, J., Roberts, B., Olarte, J.-P., Nowak Jr,
T.S., Pulsinelli, W.A., 1997. DNA fragmentation follows delayed
neuronal death in CA1 neurons exposed to transient global ische-
mia in the rat. J. Cereb. Blood Flow Metab. 17, 967±976.
Posmantur, R., McGinnis, K., Nadimpalli, R., Gilbertsen, R.,
Wang, K.K.W., 1997. Characterization of CPP32-like protease
activity following apoptotic challenge in SH-SY5Y neuroblastoma
cells. J. Neurochem. 68, 2328±2337.
Schielke, G.P., Yang, G.-Y., Shivers, B.D., Betz, A.L., 1998.
Reduced ischemic brain injury in interleukin-1Beta converting
enzyme-de®cient Mice. J. Cerebr. Blood Flow Metab. 18, 180±
185.
Schulz, J.B., Weller, M., Klockgether, T., 1996. Potassium depri-
vation-induced apoptosis of cerebellar granule neurons: a sequen-
tial requirement for new mRNA and protein synthesis, ICE-like
protease activity, and reactive oxygen species. J. Neurosci. 16,
4696±4706.
Scott, R.J., Hegyi, L., 1997. Cell death in perinatal hypoxic-ischae-
mic brain injury. Neuropathol. Appl. Neurobiol. 23, 307±314.
Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T.,
Howard, A.D., Kostura, M.J., et al., 1992. A novel heterodimeric
cysteine protease is required for interleukin-1beta processing in
monocytes. Nature 356, 768±774.
van Lookeren Campagne, M., Gill, R., 1996. Ultrastructural mor-
phological changes are not characteristic of apoptotic cell death
following focal cerebral ischemia in the rat. Neurosci. Lett. 213,
111±114.
Wang, K.K.W., Posmantur, R., Nath, R., McGinnis, K., Whitton,
M., Talanian, R.V., Glantz, S., Morrow, J., 1998. Simultaneous
degradation of a- and b-subunits of nonerythroid spectrin by cas-
pase in apoptotic cells. J. Biol. Chem. 273, 22,490±22,497.
Wang, K.K.W., Posner, A., Hajimohammadreza, I., 1996. Improved
method of total protein extraction from cultured cells for use in
protein electrophoresis and Western blotting. Biotechniques 20,
662±668.
Wiesner, D., Dawson, G., 1996. Staurosporine induces programmed
cell death in embryonic neurons and activation of the ceramide
pathway. J. Neurochem. 66, 1418±1425.
Yakolev, A.G., Knoblach, S.M., Fan, L., Fox, G.B., Goodnight, R.,
Faden, A.I., 1997. Activation of CPP32-like caspases contributes
to neuronal apoptosis and neurological dysfunction after trau-
matic brain injury. J. Neurosci. 17, 7415±7424.
R. Nath et al./ Neurochemistry International 36 (2000) 119±126 126